Aventis Gammar-P Recall
This article was originally published in The Pink Sheet Daily
Executive Summary
Aventis Behring is recalling two lots of Gammar-P intravenous 10 gram due to "an increased frequency of non-serious, labeled adverse events associated with allergic reactions," FDA said April 2